Novartis AG (NVSEF) stock analysis
In our weekly check, Novartis AG is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 4, red flags: 3.
About Novartis AG
Novartis AG is a Healthcare company (Drug Manufacturers - General) based in Switzerland, listed on OTC as NVSEF.
What our checks show for NVSEF
Red flags
- The net margin fell by 27.3 points over 5 years, to 18.1%: the company keeps less of each sale as profit.
- Recovering from its deepest fall took about 6.9 years.
- Thinly traded (about 33 thousand shares a day): buying and selling can move the price.
Warning signs
- Debt is high against equity (1.3x), although net debt is 1.7x a year of EBITDA. That limits room in a downturn.
- Revenue grew only 1.7% a year over the last 3 years.
- The dividend takes 90% of profit: little cushion if profit falls.
- The price swings a lot: 47.8% annual volatility. Expect large ups and downs.
Strengths
- Operating profit covers interest 10.9 times over.
- The gross margin is 74.3% and has risen by 4.3 points: pricing power is holding.
- Operating cash flow is 1.7x net profit: the profit arrives as real cash.
- Analysts expect earnings per share to grow about 38.7% a year over the next years.
- Analysts expect the net margin to improve by 14.5 points from today's 18.1%.
- Earnings per share grew 16.4% a year over the last 3 years.
Next earnings report: 2027-02-03
Similar companies
AZN · MRK · AMGN · GILD · NVO · ABBV
Questions
What grade does Novartis AG (NVSEF) have?
In our weekly check, Novartis AG is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 18 pass, warnings: 4, red flags: 3. The grade is a risk check, not a buy or sell recommendation.
What are the main risks of NVSEF stock?
This week's biggest flags for Novartis AG: Margins falling, Slow recovery after falls, Thinly traded. In total 7 of 25 checks show a warning or a red flag.
What does Novartis AG do?
Novartis AG is a Healthcare company (Drug Manufacturers - General) based in Switzerland, listed on OTC as NVSEF.
When does Novartis AG report earnings next?
The next earnings report is expected on 2027-02-03. We re-run the checks every week, so the grade can change after it.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-11-14
Open the full analysis